The developers of the vaccine candidate, which has been licensed to pharmaceuticals company AstraZeneca, have already published later stage trial results showing higher efficacy when a half dose is followed by a full dose, compared to a two full-dose regime. However, more work needs to be done to affirm that result.from UK News Headlines, Latest UK News and Live Updates - Times of India https://ift.tt/3h2rRwz
No comments:
Post a Comment